RU2023125855A - NEOANTIGENS AND THEIR APPLICATION - Google Patents
NEOANTIGENS AND THEIR APPLICATION Download PDFInfo
- Publication number
- RU2023125855A RU2023125855A RU2023125855A RU2023125855A RU2023125855A RU 2023125855 A RU2023125855 A RU 2023125855A RU 2023125855 A RU2023125855 A RU 2023125855A RU 2023125855 A RU2023125855 A RU 2023125855A RU 2023125855 A RU2023125855 A RU 2023125855A
- Authority
- RU
- Russia
- Prior art keywords
- polypeptide
- neoantigens
- application
- gavgvgksal
- gavgvgksa
- Prior art date
Links
Claims (6)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62/687,188 | 2018-06-19 | ||
US62/800,735 | 2019-02-04 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2021100733A Division RU2805196C2 (en) | 2018-06-19 | 2019-06-19 | Neoantigens and their application |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2023125855A true RU2023125855A (en) | 2023-10-16 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2018122823A (en) | PROTEIN MUTANTS F RSV | |
EA201990885A1 (en) | COMPOSITIONS CONTAINING SHORT PEPTIDES OBTAINED FROM PEDF AND THEIR APPLICATION | |
IL232501A (en) | Proteinase-resistant analogs of peptide or polypeptide and uses thereof | |
BR112017007816A2 (en) | pharmaceutical compositions comprising peptide variants and methods of using them | |
ES2528133T3 (en) | Peptides and compositions for prevention of cell adhesion, and methods for using them | |
NZ628987A (en) | Extended recombinant polypeptides and compositions comprising same | |
MX2017016105A (en) | Adenovirus polynucleotides and polypeptides. | |
WO2019148026A8 (en) | Il-22 fc fusion proteins and methods of use | |
CL2017003097A1 (en) | Compositions and methods for the treatment of celiac disease | |
WO2019084343A8 (en) | Peptide compositions and methods of use thereof | |
EA202192925A1 (en) | SOLID FORMS OF THE GLYT1 INHIBITOR | |
WO2020008377A3 (en) | Ionic self-assembling peptides | |
EA202190240A1 (en) | RECOMBINANT PROTEIN OPTIONS | |
EP3946410A4 (en) | Therapeutic interferon alpha 1 proteins | |
BR112018013246A2 (en) | peptide label and labeled protein including the same | |
WO2018189661A3 (en) | Methods and compounds for treating diabetes | |
RU2023125855A (en) | NEOANTIGENS AND THEIR APPLICATION | |
MX2021004879A (en) | Klk5 inhibitory peptide. | |
EA202090143A1 (en) | PHARMACEUTALLY ACCEPTABLE SALTS OF POLYPEPTIDES AND THEIR APPLICATION | |
EA201992587A1 (en) | PEPTIDES AND THEIR APPLICATION AS ANTIVIRAL AGENTS | |
EA202092963A1 (en) | NEW PROTEIN WITH ANTI-INFLAMMATORY PROPERTIES | |
JP2019218304A5 (en) | ||
WO2019237075A8 (en) | Epha2 agonists and uses thereof | |
EA202190531A1 (en) | COLLECTIONS OF PEPTIDES, PEPTIDE AGENTS AND METHODS OF THEIR APPLICATION | |
RU2022114441A (en) | MODIFIED L-ASPARAGINASE |